More than 15,000 claims against Janssen Pharmaceuticals have been filed by people who have had severe bleeding incidents after taking Xarelto, a popular blood-thinning drug. Risk of bleeding is the most serious side effect of all blood-thinning medication. Thousands of lawsuits accuse Bayer Healthcare and Janssen Pharmaceuticals, the makers of Xarelto, of not providing adequate…
DetailsOur newest member of the Showard Law Firm team is Marissa Echols. Marissa recently graduated from the University of Arizona where she studied Public Health. Her studies led her to develop an immense passion for helping others, traveling, and immersing herself into different cultures. Originally from St. Louis, Marissa enjoys reading, horseback riding, and volunteering with local…
DetailsA second round of settlements regarding the Stryker Rejuvenate and ABG II hip implants was just announced. The settlement will apply only to patients who have undergone a revision surgery prior to today, December 19, 2016. The terms of the settlement are similar to the earlier settlement of November 2014, however, there are some important…
DetailsAs you may have heard the third bellwether trial against Johnson & Johnson resulted in an award of $1.04 billion. The trial lasted twelve weeks and involved the claims of six plaintiffs. The jury found that officials of J&J’s DePuy unit knew the devices were defective yet failed to properly warn doctors and patients about…
DetailsJoin us and travel the world over during an unforgettable evening of entertainment and hope at the 2017 Tucson Heart and Stroke Ball. For 58 years the Tucson Heart and Stroke Ball has helped to advance the lifesaving mission of the American Heart Association, a mission that has impacted the lives of thousands of men, women and children throughout Southern Arizona. Contributions…
DetailsA Texas federal jury on Thursday found Johnson & Johnson’s DePuy Orthopaedics Inc. unit liable for more than $1.04 billion in a six-plaintiff bellwether trial targeting metal-shedding artificial hips that are part of its Pinnacle line, dwarfing the $150 million verdict J&J is on the hook for after a previous bellwether.
ST. LOUIS – A major victory for a plaintiff in the Johnson & Johnson talcum powder litigation took place yesterday, with a jury awarding $70.075 million to Ms. Deborah Giannecchini. This is the third substantial talc verdict against J&J this year–other huge losses have taken place, with damages awarded to plaintiffs in two separate verdicts…
DetailsThe U.S. Judicial Panel on Multidistrict Litigation has consolidated cases in Abilify, Talc and Taxotere suits among others. The Talc litigation has been transferred to New Jersey judge Freda Wolfson. She currently presides over Chakalos v. Johnson & Johnson, filed in November 2014 making it the most advanced suit. New Jersey is also the home…
DetailsWEST HARTFORD, CT (WFSB) – After receiving reports of children experiencing seizures after using one of the products, the FDA said the tablets and gels could pose a serious health risk to infants and children, “Something like that is just very, very scary to hear,” said Angel Alvarado, who is a first-time dad. His 5-month-old has…
DetailsAfter being slammed with two multimillion dollar verdicts which are currently being appealed, Johnson & Johnson is pointing the finger at plaintiffs’ lawyers claiming that we are deliberately creating confusion about the science of talc. Why were the juries so incensed that they awarded $112 million in punitive damages? Several documents obtained through the discovery…
Details